These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36352587)

  • 21. Comparison of diagnostic efficacy between
    Gao H; Li G; Fu C; Ren J; Kang F; Luo W; Yin Q; Zhou C; Li B; Lu S; Wang H; Zhang Y; Zhang Y
    Front Endocrinol (Lausanne); 2024; 15():1359655. PubMed ID: 38487344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
    Iagaru A; Mittra E; Dick DW; Gambhir SS
    Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
    Pietrzak AK; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Urol J; 2018 Sep; 15(5):242-247. PubMed ID: 29681049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison Between Tc-99m WBC SPECT/CT and MRI for the Diagnosis of Biopsy-proven Diabetic Foot Osteomyelitis.
    La Fontaine J; Bhavan K; Lam K; Van Asten S; Erdman W; Lavery LA; Öz OK
    Wounds; 2016 Aug; 28(8):271-8. PubMed ID: 27560470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.
    Damle NA; Bal C; Bandopadhyaya GP; Kumar L; Kumar P; Malhotra A; Lata S
    Jpn J Radiol; 2013 Apr; 31(4):262-9. PubMed ID: 23377765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Al-Bulushi NK; Abouzied ME
    Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skull Base Osteomyelitis: A Comprehensive Imaging Review.
    Chapman PR; Choudhary G; Singhal A
    AJNR Am J Neuroradiol; 2021 Mar; 42(3):404-413. PubMed ID: 33478944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review.
    van der Bruggen W; Bleeker-Rovers CP; Boerman OC; Gotthardt M; Oyen WJ
    Semin Nucl Med; 2010 Jan; 40(1):3-15. PubMed ID: 19958846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-FDG PET imaging for treatment response assessment and management guidance in patients with skull base osteomyelitis.
    Saxena A; Subramanyam P; Sarma M; Bhad B; Bhaskaran R; Palaniswamy SS
    Nucl Med Commun; 2024 Jul; 45(7):589-600. PubMed ID: 38618743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
    Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
    Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
    Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nonspecific osteomyelitis in childhood and adolescence. The contribution of imaging diagnosis].
    Urso S; Pacciani E; Fariello G; Colajacomo M; Fassari FM; Randisi F; Certo A; Liberatore M; Pagnotta G
    Radiol Med; 1995 Sep; 90(3):212-8. PubMed ID: 7501824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of postoperative osteomyelitis of the sternum comparing CT and dual Tc-99m MDP bone and In-111 WBC SPECT.
    Bessette PR; Hanson MJ; Czarnecki DJ; Yuille DL; Rankin JJ
    Clin Nucl Med; 1993 Mar; 18(3):197-202. PubMed ID: 8462208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
    Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
    Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma.
    Lee I; Byun BH; Lim I; Kim BI; Kong CB; Song WS; Cho WH; Koh JS; Lim SM
    Medicine (Baltimore); 2018 Sep; 97(37):e12318. PubMed ID: 30212975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of osteomyelitis in the diabetic foot with a 99mTc-HMPAO leucocyte scintigraphy combined with a 99mTc-MDP bone scintigraphy.
    Poirier JY; Garin E; Derrien C; Devillers A; Moisan A; Bourguet P; Maugendre D
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):485-90. PubMed ID: 12522329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis.
    Guhlmann A; Brecht-Krauss D; Suger G; Glatting G; Kotzerke J; Kinzl L; Reske SN
    J Nucl Med; 1998 Dec; 39(12):2145-52. PubMed ID: 9867159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis.
    Chatziioannou S; Papamichos O; Gamaletsou MN; Georgakopoulos A; Kostomitsopoulos NG; Tseleni-Balafouta S; Papaparaskevas J; Walsh TJ; Pneumaticos SG; Sipsas NV
    J Orthop Surg Res; 2015 Aug; 10():132. PubMed ID: 26306506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.